Notice Number: NOT-CA-20-006
Release Date: November 20, 2019
National Cancer Institute (NCI)
The purpose of this Notice is to modify PA-18-842, “Administrative Supplements to Support Cancer Disparity Collaborative Research)," by adding five additional activity codes (R00, R21, R21/R33, UH2/UH3, and UG3/UH3) as awards eligible for the specified administrative supplements and by adding an additional (i.e., a new penultimate) application due date, together with the associated open and start dates.
In Part 1. Overview Information, under Activity Code, five additional activity codes (i.e., R00, R21, R21/R33, UG3/UH3, and UH2/UH3) have been added.
Additional funds may be awarded as supplements to parent awards using the following Activity Code(s):
Administrative supplement requests must be submitted on paper for the following activity codes:
Administrative supplement requests may be submitted electronically for the following activity codes:
R00 (R00 portion only of K99/R00) Research Transition Award
R01 Research Project Grant
R21 Exploratory/Developmental Grants
UG1 Clinical Research Cooperative Agreements - Single Project
UG3/UH3 Exploratory/Developmental Cooperative Agreement Phase I/Phase II
UH2/UH3 Exploratory/Developmental Cooperative Agreement Phase I/Phase II
UM1 Multi-Component Research Project Cooperative Agreements
In Part 1. Overview Information, under Key Dates, one additional series of sequentially linked open, application due, and start dates have been added.
August 10, 2018; August 10, 2019; January 10, 2020; August 10, 2020
Application Due Date(s)
September 10, 2018, September 10, 2019, February 10, 2020; September 10, 2020, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review
Advisory Council Review
Earliest Start Date
October 2018; October 2019; March 2020; October 2020
Please direct all inquiries to:
Elizabeth Perruccio, Ph.D.
National Cancer Institute